(Reuters) - The U.S. Food and Drug Administration on Thursday approved a new drug for advanced colon cancer developed by Bayer AG, a month ahead of the agency's expected action date for a decision. The drug, to be sold under the brand name Stivarga, was approved to treat colon cancer that has progressed after prior treatment or that has spread to other parts of the body, the agency said. "Someone has clearly lit a fire under the FDA," Sanford Bernstein analyst Geoffrey Porges said of the speedy approval. ...
Source: http://news.yahoo.com/eu-raids-lead-recycling-firms-cartel-investigation-085408630--finance.html
huntsville al channel 2 news adrienne bailon yelp stock honda classic news channel 5 nashville weather
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.